Published Papers & Misc - MORI MASAAKI

Division display  81 - 100 of about 646 ／  All the affair displays >>

  1. Kobayashi, I. and Akioka, S. and Kobayashi, N. and Iwata, N. and Takezaki, S. and Nakaseko, H. and Sato, S. and Nishida, Y. and Nozawa, T. and Yamasaki, Y. and Yamazaki, K. and Arai, S. and Nishino, I. and Mori, M.. Clinical practice guidance for juvenile dermatomyositis (JDM) 2018-Update Mod Rheumatol. 2020; 1-13.

  2. Matsumoto, T. and Matsui, T. and Hirano, F. and Tohma, S. and Mori, M.. Disease activity, treatment and long-term prognosis of adult juvenile idiopathic arthritis patients compared with rheumatoid arthritis patients Mod Rheumatol. 2020; 30 (1): 78-84.

  3. Shimizu, M. and Mizuta, M. and Okamoto, N. and Yasumi, T. and Iwata, N. and Umebayashi, H. and Okura, Y. and Kinjo, N. and Kubota, T. and Nakagishi, Y. and Nishimura, K. and Mohri, M. and Yashiro, M. and Yasumura, J. and Wakiguchi, H. and Mori, M.. Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis Pediatr Rheumatol Online J. 2020; 18 (1): 2.

  4. Tanaka, Y. and Kuwana, M. and Fujii, T. and Kameda, H. and Muro, Y. and Fujio, K. and Itoh, Y. and Yasuoka, H. and Fukaya, S. and Ashihara, K. and Hirano, D. and Ohmura, K. and Tabuchi, Y. and Hasegawa, H. and Matsumiya, R. and Shirai, Y. and Ogura, T. and Tsuchida, Y. and Ogawa-Momohara, M. and Narazaki, H. and Inoue, Y. and Miyagawa, I. and Nakano, K. and Hirata, S. and Mori, M.. 2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases Mod Rheumatol. 2020; 1-5.

  5. Asano Tomoyuki, Sato Shuzo, Furuya Makiko Yashiro, Takahashi Hiroshi, Shichishima-Nakamura Akiko, Ohkawara Hiroshi, Fujiwara Tatsuo, Gunji Naohiko, Hashimoto Choichiro, Momma Tomoyuki, Saito Motonobu, Nakano Hiroshi, Watanabe Guy, Temmoku Jumpei, Fujita Yuya, Matsuoka Naoki, Kobayashi Hiroko, Watanabe Hiroshi, Mouri Mariko, Mashiyama Fumi, Sakuma Hiroko, Ohira Hiromasa, Mori Masaaki, Ikezoe Takayuki, Migita Kiyoshi. Intestinal Behcet disease associated with myelodysplastic syndrome accompanying trisomy 8 successfully treated with abdominal surgery followed by hematopoietic stem cell transplantation A case report MEDICINE. 2019.11; 98 (46): ( DOI )

  6. Miyamae Takako, Akioka Shinji, Igarashi Toru, Inoue Yuzaburo, Hashimoto Motomu, Matsui Toshihiro, Nishiyama Susumu, Ohshima Shiro, Umebayashi Hiroaki, Yasumi Takahiro, Mori Masaaki. CLINICAL PRACTICE GUIDANCE FOR THE TRANSITIONAL CARE OF YOUNG PEOPLE WITH JUVENILE-ONSET RHEUMATIC DISORDERS IN JAPAN ANNALS OF THE RHEUMATIC DISEASES. 2019.06; 78 1978-1979. ( DOI )

  7. Shimizu Masaki, Mizuta Mao, Yasumi Takahiro, Iwata Naomi, Okura Yuka, Kinjo Noriko, Umebayashi Hiroaki, Kubota Tomohiro, Nakagishi Yasuo, Nishimura Kenichi, Yashiro Masato, Yasumura Junko, Wakiguchi Hiroyuki, Okamoto Nami, Mori Masaaki. TOCILIZUMAB MODIFIES CLINICAL MANIFESTATIONS AND LABORATORY FEATURES OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED MACROPHAGE ACTIVATION SYNDROME ANNALS OF THE RHEUMATIC DISEASES. 2019.06; 78 1989. ( DOI )

  8. Mori Masaaki, Yanagimachi Katsumasa. DEVELOPMENT OF A NOVEL DIAGNOSTIC METHOD FOR ATYPICAL AND TREATMENT-REFRACTORY KAWASAKI DISEASE USING NEWLY IDENTIFIED PROTEINS AS BIOMARKERS ANNALS OF THE RHEUMATIC DISEASES. 2019.06; 78 1979. ( DOI )

  9. Sato Satoshi, Yamaguchi Kenichi, Mori Masaaki. CLINICAL FEATURE OF ACUTE RHEUMATIC FEVER AND POST-STREPTOCOCCAL REACTIVE ARTHRITIS ANNALS OF THE RHEUMATIC DISEASES. 2019.06; 78 1348-1349. ( DOI )

  10. Maeda, Y. and Takasawa, K. and Ishii, T. and Nagashima, A. and Mouri, M. and Kunieda, J. and Morisaki, H. and Ito, T. and Mori, M. and Kashimada, K. and Doi, S. and Morio, T.. A Nonsense SMAD3 Mutation in a Girl with Familial Thoracic Aortic Aneurysm and Dissection without Joint Abnormality Cardiology. 2019; 144 (1-2): 53-59.

  11. Mori, M.. In order to identify immunocompromised patients, what should general pediatricians do first? Pediatr Int. 2019; 61 (1): 4.

  12. Asano, T. and Sato, S. and Furuya, M. Y. and Takahashi, H. and Shichishima-Nakamura, A. and Ohkawara, H. and Fujiwara, T. and Gunji, N. and Hashimoto, C. and Momma, T. and Saito, M. and Nakano, H. and Watanabe, G. and Temmoku, J. and Fujita, Y. and Matsuoka, N. and Kobayashi, H. and Watanabe, H. and Mouri, M. and Mashiyama, F. and Sakuma, H. and Ohira, H. and Mori, M. and Ikezoe, T. and Migita, K.. Intestinal Behcet disease associated with myelodysplastic syndrome accompanying trisomy 8 successfully treated with abdominal surgery followed by hematopoietic stem cell transplantation: A case report Medicine (Baltimore). 2019; 98 (46): e17979.

  13. Yasumura, J. and Yashiro, M. and Okamoto, N. and Shabana, K. and Umebayashi, H. and Iwata, N. and Okura, Y. and Kubota, T. and Shimizu, M. and Tomiita, M. and Nakagishi, Y. and Nishimura, K. and Hara, R. and Mizuta, M. and Yasumi, T. and Yamaide, F. and Wakiguchi, H. and Kobayashi, M. and Mori, M.. Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ) Pediatr Rheumatol Online J. 2019; 17 (1): 15.

  14. Terashita, S. and Tanaka, T. and Taneichi, H. and Adachi, Y. and Mori, M.. Mycophenolate mofetil and prednisolone for cerebral sinus venous thrombosis with Behcet's disease Pediatr Int. 2019; 61 (9): 920-922.

  15. Hara, R. and Umebayashi, H. and Takei, S. and Okamoto, N. and Iwata, N. and Yamasaki, Y. and Nakagishi, Y. and Kizawa, T. and Kobayashi, I. and Imagawa, T. and Kinjo, N. and Amano, N. and Takahashi, Y. and Mori, M. and Itoh, Y. and Yokota, S.. Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study Pediatr Rheumatol Online J. 2019; 17 (1): 17.

  16. 井上, 健斗 and 森, 雅亮. 【小児における抗菌薬適正使用-最新の考え方からのアプローチ】小児における抗真菌薬の選び方・使い方 感染と抗菌薬. 2019; 22 (2): 138-144.

  17. 岡田, 賢司 and 水野, 美穂子 and 森内, 浩幸 and 楠田, 聡 and 森岡, 一朗 and 森, 雅亮 and 岡本, 圭祐 and 岡田, 邦之 and 吉原, 重美 and 山岸, 敬幸 and 横山, 詩子 and 久保田, 知洋 and 工藤, 寿子 and 高木, 正稔 and 伊藤, 秀一 and 金森, 豊 and 笹原, 洋二 and 日本小児科学会予防接種・感染症対策委員会「日本におけるパリビズマブの使用に関するガイドライン」改訂検討ワーキンググループ and 日本小児科学会 and 日本新生児成育医学会 and 日本小児感染症学会 and 日本小児呼吸器学会 and 日本小児循環器学会 and 日本小児リウマチ学会 and 日本小児血液・がん学会 and 日本小児腎臓病学会 and 日本小児外科学会 and 日本免疫不全・自己炎症学会. 日本におけるパリビズマブの使用に関するコンセンサスガイドライン 日本小児科学会雑誌. 2019; 123 (5): 807-813.

  18. Nakaseko, H. and Iwata, N. and Yasuoka, R. and Kohagura, T. and Abe, N. and Kawabe, S. and Mori, M.. Pharmacokinetics of mycophenolate mofetil in juvenile patients with autoimmune diseases Mod Rheumatol. 2019; 29 (6): 1002-1006.

  19. Sakurai, N. and Hino-Shishikura, A. and Nozawa, T. and Kamide, H. and Ohara, A. and Nishimura, K. and Kikuchi, M. and Hara, R. and Mori, M. and Ito, S.. Clinical significance of subcutaneous fat and fascial involvement in juvenile dermatomyositis Mod Rheumatol. 2019; 29 (5): 808-813.

  20. Okamoto, N. and Yokota, S. and Takei, S. and Okura, Y. and Kubota, T. and Shimizu, M. and Nozawa, T. and Iwata, N. and Umebayashi, H. and Kinjo, N. and Kunishima, T. and Yasumura, J. and Mori, M.. Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018 Mod Rheumatol. 2019; 29 (1): 41-59.

< PREV - NEXT >

To the head of this page.▲